A Randomized, Placebo-Controlled, Double-blind, Dose-Ranging, Multicenter, Phase IIb Clinical Trial to Investigate the Efficacy and Safety of allo-APZ2-CVU on Wound Healing of Therapy-Resistant Chronic Venous Ulcer (CVU)

Chronic venous ulcers (CVU)

Complete wound closure at Week 18 already persisting for at least two weeks;, Adverse events;

Wound size change in percent at each post-baseline follow-up visit;, Time to complete wound closure;, Complete wound closures at each post-baseline follow-up visit;, Duration of wound closure;, Recurrence of the wound;, Quality of wound healing at each post-baseline follow-up visit;, Assessment of Quality of Life using the Wound-Quality of Life Questionnaire at V8, V11, V14;, Pain assessment as per numerical rating scale on each post-baseline efficacy follow-up visit;, Physical examination and vital signs at V14.

No related papers found yet.

Germany